Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children’s oncology group ARST0332 trial

Sapna Oberoi, MD

doi:10.1093/jnci/djag211

Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children’s oncology group ARST0332 trial

2026-06-27

0

OA

AI

S

Sapna Oberoi, MD *

Z

Zhengya Gao, MS

W

Wei Xue, PhD

R

Robert L Randall, MD

C

Cheryl M Coffin, MD

L

Lynn Million, MD

S

Suzanne Wolden, MD

M

Mary Beth McCarville, MD

S

Simon C Kao, MD

R

Rajkumar Venkatramani, MD

S

Sheri L Spunt, MD

A

Aaron R Weiss, DO

DOI：10.1093/jnci/djag211

Original

Original request for help

Save

Abstract

En 中文

We evaluated clinical characteristics, response to therapy, event-free and overall survival (EFS and OS), patterns of recurrence/progression, and factors associated with survival in patients with metastatic non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) treated on the Children’s Oncology Group ARST0332 trial.

Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children’s oncology group ARST0332 trial

Abstract

Journal

Organization

Cited Papers

Citing Papers